Joon Young Hur

7PUBLICATIONS
27CO-AUTHORS
Predictive and prognostic markersImmunogenetics (incl. genetic immunology)Haematological tumoursCancer therapy (excl. chemotherapy and radiation therapy)Cancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|May 06, 2026
Histology-defined activated cancer-associated fibroblasts are associated with poor survival in diffuse-type gastric adenocarcinoma.

|Feb 24, 2026
The surgery for the patients with intestinal non‑Hodgkin lymphomas: a nationwide study.

Jiyeong Kim, Jun Ho Lee, Sung Hwan Hwang

|Sep 30, 2024
p27 Cell Cycle Inhibitor and Survival in Luminal-Type Breast Cancer: Gene Ontology, Machine Learning, and Drug Screening Analysis.

In Ah Park, Yung-Kyun Noh, Kyueng-Whan Min

|Apr 19, 2024
CLDN18: Clinical, Pathological, and Genetic Signatures with Drug Screening in Gastric Adenocarcinoma.

Joon Young Hur, Kyueng-Whan Min, Yung-Kyun Noh

|Jan 11, 2021
Immunological Characteristics of Hyperprogressive Disease in Patients with Non-small Cell Lung Cancer Treated with Anti-PD-1/PD-L1 Abs.

Kyung Hwan Kim, Joon Young Hur, Jiae Koh

|Sep 28, 2020
Docetaxel rechallenge in metastatic castration-resistant prostate cancer: A retrospective, single-center study.

Seonggyu Byeon, Hyera Kim, Jinchul Kim

Pageof 2

Frequent Collaborators

2 joint publications

Minsuk Kwon

2 joint publications

Byoung Kwan Son

2 joint publications

Dong-Hoon Kim

2 joint publications

Mi Jung Kwon